找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Interferons; Biological Activitie Carlo Aul,Wolfgang Schneider Conference proceedings 1997 Springer-Verlag Berlin Heidelberg 1997 Autoimmun

[复制链接]
楼主: 哪能仁慈
发表于 2025-3-23 11:16:07 | 显示全部楼层
发表于 2025-3-23 16:12:43 | 显示全部楼层
Treatment Strategies in Multiple Myeloma: Biotherapy with Interferons,100 000 persons in China to approximately four per 100 000 in the United States and most Western industrialized countries. Blacks are affected twice as often as Caucasians, and men more often than women. Multiple myeloma is clearly an age-dependent disease, with affected individuals having a mean ag
发表于 2025-3-23 20:58:49 | 显示全部楼层
发表于 2025-3-23 23:36:32 | 显示全部楼层
发表于 2025-3-24 05:59:24 | 显示全部楼层
Cutaneous Lymphomas: A Heterogeneous Group of Lymphoproliferative Disorders at Least in Part Sensitous lymphoproliferative disorders can present in the skin alone, in the skin and extracutaneous sites, or as extracutaneous disease with secondary skin involvement. In a strict sense, they are lymphoproliferative disorders primarily manifesting in the skin and being confined to the skin for ever or
发表于 2025-3-24 09:21:02 | 显示全部楼层
Current Therapy Strategies for Malignant Melanoma with Special Regard to Immunotherapy with Cytokin(MM) develops as a result of neoplastic transformation of melanocytes either in or near a precursor lesion, e.g., a nevus, or de novo in normal skin. MM is one of the most dangerous malignant tumors in general and the most common reason for the death of patients with a cutaneous neoplasia [1–5]. MM
发表于 2025-3-24 11:34:11 | 显示全部楼层
发表于 2025-3-24 14:54:25 | 显示全部楼层
Interferons in the Treatment of Genitourinary Tumors,s well as against experimental tumor models in animal experiments has stimulated the investigation of these cytokines in the treatment of human malignancy. Looking at the innumerous case reports and studies reported so far the rationale for using interferons in the treatment of genitourinary tumors
发表于 2025-3-24 22:06:03 | 显示全部楼层
发表于 2025-3-25 00:55:21 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-17 23:07
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表